Rithm Acquisition Corp. (RAC) News
Follow Rithm Acquisition Corp. (RAC) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 2 public stories across 2 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Racura Oncology opens Korean recruitment for RC220 Phase 1 trial
Racura Oncology opened Korean recruitment for RC220, a Phase 1 solid tumours trial.
EQUITY | Sep 01, 2026, 01:46 AM UTC
L
RAC net loss more than doubled as R&D accelerated
RAC reported a net loss that more than doubled as R&D accelerated, while strong funding supports clinical progress.
EQUITY | Aug 27, 2026, 07:57 AM UTC